| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:ProfitLoss in link role http://www.inventivapharma.com/role/CompteDeRsultat reported sum -33,619,000 computed sum -33,620,000 context P01_01_2020To12_31_2020 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:ProfitLoss in link role http://www.inventivapharma.com/role/CompteDeRsultat reported sum -49,635,000 computed sum -49,636,000 context P01_01_2021To12_31_2021 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:ProfitLoss in link role http://www.inventivapharma.com/role/CompteDeRsultat reported sum -30,218,000 computed sum -30,219,000 context P01_01_2019To12_31_2019 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:FinanceIncomeCost in link role http://www.inventivapharma.com/role/CompteDeRsultat reported sum 2,842,000 computed sum 2,843,000 context P01_01_2021To12_31_2021 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:FinanceIncomeCost in link role http://www.inventivapharma.com/role/CompteDeRsultat reported sum 93,000 computed sum 94,000 context P01_01_2019To12_31_2019 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:Assets in link role http://www.inventivapharma.com/role/EtatDeLaSituationFinancire reported sum 56,960,000 computed sum 56,959,000 context PAsOn12_31_2019 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:Assets in link role http://www.inventivapharma.com/role/EtatDeLaSituationFinancire reported sum 121,985,000 computed sum 121,986,000 context PAsOn12_31_2021 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:EquityAndLiabilities in link role http://www.inventivapharma.com/role/EtatDeLaSituationFinancire reported sum 138,920,000 computed sum 138,919,000 context PAsOn12_31_2020 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:CurrentLiabilities in link role http://www.inventivapharma.com/role/EtatDeLaSituationFinancire reported sum 13,865,000 computed sum 13,866,000 context PAsOn12_31_2019 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:CurrentLiabilities in link role http://www.inventivapharma.com/role/EtatDeLaSituationFinancire reported sum 13,908,000 computed sum 13,909,000 context PAsOn12_31_2020 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:NoncurrentLiabilities in link role http://www.inventivapharma.com/role/EtatDeLaSituationFinancire reported sum 13,800,000 computed sum 13,799,000 context PAsOn12_31_2020 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:Equity in link role http://www.inventivapharma.com/role/EtatDeLaSituationFinancire reported sum 88,866,000 computed sum 88,867,000 context PAsOn12_31_2021 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:Equity in link role http://www.inventivapharma.com/role/EtatDeLaSituationFinancire reported sum 111,211,000 computed sum 111,212,000 context PAsOn12_31_2020 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:CashFlowsFromUsedInInvestingActivities in link role http://www.inventivapharma.com/role/EtatDesFluxDeTrsorerie reported sum -1,793,000 computed sum -1,794,000 context P01_01_2021To12_31_2021 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:IncreaseDecreaseInWorkingCapital in link role http://www.inventivapharma.com/role/EtatDesFluxDeTrsorerie reported sum -3,130,000 computed sum -3,128,000 context P01_01_2019To12_31_2019 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital in link role http://www.inventivapharma.com/role/EtatDesFluxDeTrsorerie reported sum -37,041,000 computed sum -37,040,000 context P01_01_2020To12_31_2020 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital in link role http://www.inventivapharma.com/role/EtatDesFluxDeTrsorerie reported sum -56,565,000 computed sum -56,564,000 context P01_01_2021To12_31_2021 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:ComprehensiveIncome in link role http://www.inventivapharma.com/role/EtatDesVariationsDesCapitauxPropres reported sum -30,315,000 computed sum -30,314,000 context P01_01_2019To12_31_2019 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:ComprehensiveIncome in link role http://www.inventivapharma.com/role/EtatDuRsultatGlobal reported sum -30,315,000 computed sum -30,314,000 context P01_01_2019To12_31_2019 unit Unit_EUR unreportedContributingItems none |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:ComprehensiveIncome in link role http://www.inventivapharma.com/role/EtatDuRsultatGlobal reported sum -49,000 computed sum 0 context P01_01_2020To12_31_2020_RetainedEarningsExcludingProfitLossForReportingPeriodAndTreasurySharesMemberifrsfullComponentsOfEquityAxis unit Unit_EUR unreportedContributingItems ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax, ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:ComprehensiveIncome in link role http://www.inventivapharma.com/role/EtatDuRsultatGlobal reported sum -96,000 computed sum 0 context P01_01_2019To12_31_2019_RetainedEarningsExcludingProfitLossForReportingPeriodAndTreasurySharesMemberifrsfullComponentsOfEquityAxis unit Unit_EUR unreportedContributingItems ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax, ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:ComprehensiveIncome in link role http://www.inventivapharma.com/role/EtatDuRsultatGlobal reported sum 82,000 computed sum 0 context P01_01_2021To12_31_2021_RetainedEarningsExcludingProfitLossForReportingPeriodAndTreasurySharesMemberifrsfullComponentsOfEquityAxis unit Unit_EUR unreportedContributingItems ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax, ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax |
| INCONSISTENCY |
xbrl.5.2.5.2:calcInconsistency |
Calculation inconsistent from ifrs-full:ComprehensiveIncome in link role http://www.inventivapharma.com/role/EtatDuRsultatGlobal reported sum -164,000 computed sum 0 context P01_01_2021To12_31_2021_ReserveOfExchangeDifferencesOnTranslationMemberifrsfullComponentsOfEquityAxis unit Unit_EUR unreportedContributingItems ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax, ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax |
| WARNING |
message:man_ExplanationOfChangeInNameOfReportingEntityOrOtherMeansOfIdentificationFromEndOfPrecedingReportingPeriod |
missingMandatoryMarkups: According to the Regulatory Technical Standards on European Single Electronic Format, the element "Explanation of change in name of reporting entity or other means of identification from end of preceding reporting period" is part of the mandatory list of tags that must be applied if corresponding information is present in a report. Please make sure that you applied this tag in your report. |
| WARNING |
message:man_NameOfUltimateParentOfGroup |
missingMandatoryMarkups: According to the Regulatory Technical Standards on European Single Electronic Format, the element "Name of ultimate parent of group" is part of the mandatory list of tags that must be applied if corresponding information is present in a report. Please make sure that you applied this tag in your report. |
| WARNING |
message:man_NameOfParentEntity |
missingMandatoryMarkups: According to the Regulatory Technical Standards on European Single Electronic Format, the element "Name of parent entity" is part of the mandatory list of tags that must be applied if corresponding information is present in a report. Please make sure that you applied this tag in your report. |
